NOTE: This order is nonprecedential.

United States Court of Appeals for the Federal Circuit

2009-1427

SANOFI-AVENTIS U.S. LLC, SANOFI-AVENTIS, and

DEBIOPHARM S.A.,

Plaintiffs-Appellants,

v.

SANDOZ, INC.,

Defendant-Appellee,

and

TEVA PARENTERAL MEDICINES, INC., TEVA PHARMACEUTICALS USA, INC., and

PHARMACHEMIE BV,

Defendants-Appellees,

and

MAYNE PHARMA LIMITED, MAYNE PHARMA (USA) INC., HOSPIRA AUSTRALIA

PTY LTD., and HOSPIRA, INC.,

Defendants-Appellees,

and

BARR LABORATORIES, INC. and PLIVA-LACHEMA A.S.,

Defendants-Appellees,

and

W.C. HERAEUS GMBH,

Defendant-Appellee,

and

APP PHARMACEUTICALS, INC. and ABRAXIS BIOSCIENCE, INC.,
Defendants-Appellees,

and

ACTAVIS TOTOWA LLC, ACTAVIS, INC., and ACTAVIS GROUP HF,

Defendants-Appellees,

and

FRESENIUS KABI ONCOLOGY PLC (formerly known as Dabur Oncology plc) and

FRESENIUS KABI PHARMA LIMITED (formerly known as Dabur Pharma Limited),

Defendants-Appellees,

and

SUN PHARMACEUTICAL INDUSTRIES LTD. and CARACO PHARMACEUTICAL

LABORATORIES, LTD.,

Defendants-Appellees,

and

EBEWE PHARMA GES.M.B.H. NFG KG,

Defendants,

and

MUSTAFA NEVZAT ILAC SANAYII A.S. (also known as MN Pharmaceuticals), PAR

PHARMACEUTICAL COMPANIES, INC., and PAR PHARMACEUTICAL, INC.,

Defendants-Appellees.

On appeal from the United States District Court for the District of New Jersey in case

no. 3:07-cv-2762, Judge Joel A. Pisano.

ON MOTION

Before MAYER, CLEVENGER, and RADER, Circuit Judges.

MAYER, Circuit Judge.

ORDER

2009-1427	 - 2 -
Mayne Pharma Limited et al. (Mayne) and Teva Parenteral et al. (Teva) move for

clarification of the court's July 10, 2009 order granting Sanofi-Aventis U.S. LLC et al.'s

(Sanofi) motion for a stay, pending appeal, of the judgment of the United States District

Court for the District of New Jersey entered on June 30, 2009 and also move for a

conditional limited remand to the district court for the purpose of fixing the amount of a

supersedeas bond. Sandoz, Inc. responds. Mayne and Teva move for a 14-day

extension of time, until August 7, 2009, to file a petition for panel rehearing and/or

rehearing en banc of the court's July 10 order. Ebewe Pharma Ges.m.b.H. Nfg.KG

moves for leave to be removed from this appeal due to a consent judgment entered by

the district court resolving the litigation between Ebewe and Sanofi.

Upon consideration thereof,

IT IS ORDERED THAT:

The motion for clarification is denied.

The motion for a limited remand is deemed moot.

The motion for an extension of time to file a rehearing petition is granted.

The motion to remove Ebewe from this appeal is granted to the extent that

Ebewe is no longer designated as an appellee in the court's caption. The revised

official caption is reflected above.

FOR THE COURT

JUL 24 2009 /s/ Jan Horbalv

Date Jan Horbaly

Clerk

Pits, U.S. wow oF APPEALS PM

THE FEDERAL CIRCUIT

2009-1427	 - 3 -

JUL 2 4 2009

JAN NONtimur

CLERK
cc:

	Dominick A. Conde, Esq.

Frederick H. Rein, Esq.

Gail J. Standish, Esq.

Patricia J. Thompson, Esq.

Scott B. Feder, Esq.

Steven Lieberman, Esq.

Steven A. Maddox, Esq.

Charles D. Ossola, Esq.

Andrew M. Berdon, Esq.

Daniel G. Brown, Esq.

Steven H. Sklar, Esq.

s19